Analyst Upgrades Automatic Data Processing to Equal Weight Sets 214 Price Target Bhatia Communications Shares Rise 3 on Strong Q4 FY26 Earnings Dividend Announcement Amid Market Selloff Solar Panel Sales Rise as Businesses and Consumers Seek Cost Savings Gen Z Bargain Hunters Drive Gains for Discount Retailers Walmart and Ross Post Office Horizon Inquiry Faces FiveYear Delay Without 193m Funding Boost Police Chief Warns OpenAI Reportedly Plans Confidential IPO Filing Aiming to Lead AI Race CLDI Q4 2025 Earnings Significant EPS Beat Amid Ongoing Clinical Development NiSource NI Q1 2026 Earnings EPS Falls Short But Stock Gains on Operational Resilience US Energy Corp USEG Q1 2026 Earnings EPS Misses Estimates Despite Stock Rally KNSL Q1 2026 Earnings EPS Surges Past Estimates on Strong Underwriting Performance ABCB Q1 2026 Earnings EPS Beats Estimates Stock Slides Slightly NCLH Q1 2026 Earnings EPS Beat by 583 Drives Strong Stock Surge PetMed Express PETS Faces Continued Pressure Amid 36 Decline Testing Key Support Levels OReilly Automotive ORLY Edges Lower Amid Consolidation Near Key Support Gesher Acquisition Corp II Warrants GSHRW Rallies 949 as Price Approaches Resistance at 025 NHPAP Preferred Stock Maintains Stability with Modest Uptick Canterbury Park CPHC Holds Steady Near Resistance After Modest Gain Middle East Conflict Challenges Gulf Regions AI Hub Ambitions PPTA Q1 2026 Earnings Widening Losses Amid StantecFinanced Stibnite Gold Project Progress Mount Logan Capital 800 Notes Due 2031 MLCIL Hold Steady Near 23 as Trading Volume Remains Muted Grupo Cibest CIB Q4 2025 Earnings Massive EPS Miss Triggers Unexpected Stock Rally BTDR Q1 2026 Earnings EPS Miss Exceeds 73 as Mining Headwinds Persist NRG Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Stock Edges Higher UL Solutions Inc ULS Q1 2026 Earnings Strong Profit Beat Amid Solid Operational Execution UNF Q1 2026 Earnings EPS Beats Estimates Stock Edges Lower BWEN Q1 2026 Earnings NarrowerThanExpected Loss Drives DoubleDigit Stock Rally Soleno Therapeutics SLNO Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Refocuses on Clinical Milestones